The proposed research has the following objectives: Based off findings from the "Development of a Resiliency Program for Siblings of Children with Autism Spectrum Disorder" qualitative focus group study (protocol 2019P002284), the aim is to determine the feasibility and acceptability, of an 8-session Relaxation Response Resiliency (SibChat) program for siblings of children with ASD. We primarily aim to test the preliminary effectiveness of a pilot waitlist controlled trial on improving resiliency and stress coping, This will be assessed by comparing Baseline-3 mo. scores on primary and secondary outcome measures between the Immediate and Waitlist control groups. Among participants randomized to both conditions, we secondarily aim to investigate the extent of pre-post changes in primary and secondary outcomes. Among immediate condition group only, we also aim to assess whether end-of-treatment (3 mo. post enrollment) improvements will be sustained at 6-mo. post enrollment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility assessed by the number participants enrolled.
Timeframe: 6 months
Feasibility assessed by the number SibChat-3RP of sessions attended
Timeframe: 8 weeks
Feasibility assessed by the survey retention post intervention.
Timeframe: 6 months
Acceptability assessed using the participant feedback survey
Timeframe: 3 months
Acceptability assessed by relaxation response adherence
Timeframe: 3 months
Effectiveness of trial on improving stress coping ability (assessed using Measure of Current Status-A)
Timeframe: 3 months
Effectiveness of trial on improving resiliency (assessed using Current Experiences Scale)
Timeframe: 3 months